This site is intended for healthcare professionals only
LoginRegister
NTAGI recommends coronavirus precaution dose before 9 months for those travelling abroadNTAGI recommends coronavirus precaution dose before 9 months for those travelling abroad
Journal Club - Meningitis vaccine to tackle drug resistance in Neisseria gonorrhoeaeJournal Club - Meningitis vaccine to tackle drug resistance in Neisseria gonorrhoeae
AstraZeneca booster effective against severe COVID: UK studyAstraZeneca booster effective against severe COVID: UK study
Recombinant plant-based Covid-19 vaccine promising for infection control: NEJMRecombinant plant-based Covid-19 vaccine promising for infection control: NEJM
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccineCDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age groupBharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 yearsNovavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years
Journal Club - Antibiotics in children below 2 years to cause low vaccine responseJournal Club - Antibiotics in children below 2 years to cause low vaccine response
Supreme Court Upholds TelanganaSC finds no haste in granting EUA to covishield, covaxin
Antibiotics use in children below 2 years tied to reduced vaccine response: StudyAntibiotics use in children below 2 years tied to reduced vaccine response: Study
NTAGI panel recommends Sputnik V first dose as precautionary doseNTAGI panel recommends Sputnik V first dose as precautionary dose
USFDA VRBPA committee to review Novavax COVID vaccineUSFDA VRBPA committee to review Novavax COVID vaccine
X